home / stock / drtsw / drtsw quote
Last: | $0.23 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.23 |
High: | $0 |
Low: | $0 |
Volume: | 13 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.23 | $0 | $0.23 | $0 | $0 | 13 | 07-03-2024 |
$0.23 | $0.260001 | $0.23 | $0.260001 | $0.23 | 6,169 | 07-02-2024 |
$0.25 | $0.2673 | $0.25 | $0.2673 | $0.25 | 1,766 | 07-01-2024 |
$0.227975 | $0 | $0.227975 | $0 | $0 | 139 | 06-28-2024 |
$0.227975 | $0.25 | $0.227975 | $0.25 | $0.220101 | 1,239 | 06-27-2024 |
$0.2277 | $0.25 | $0.2277 | $0.25 | $0.2072 | 5,416 | 06-26-2024 |
$0.25 | $0.25 | $0.25 | $0.25 | $0.233 | 17,818 | 06-25-2024 |
$0.25 | $0.2599 | $0.25 | $0.2599 | $0.25 | 231 | 06-24-2024 |
$0.25 | $0.25 | $0.25 | $0.2588 | $0.25 | 6,059 | 06-21-2024 |
$0.257501 | $0.269899 | $0.257501 | $0.269899 | $0.25 | 1,463 | 06-20-2024 |
$0.2525 | $0.25 | $0.2525 | $0.2527 | $0.23 | 4,724 | 06-19-2024 |
$0.2525 | $0.25 | $0.2525 | $0.252738 | $0.23 | 4,724 | 06-18-2024 |
$0.25 | $0.25 | $0.25 | $0.252626 | $0.2201 | 13,514 | 06-17-2024 |
$0.2475 | $0.255 | $0.2475 | $0.255 | $0.2475 | 5,378 | 06-14-2024 |
$0.2546 | $0.2546 | $0.2546 | $0.2546 | $0.2546 | 1,000 | 06-13-2024 |
$0.26 | $0.25 | $0.26 | $0.260001 | $0.25 | 8,194 | 06-12-2024 |
$0.24 | $0.25 | $0.24 | $0.25 | $0.24 | 5,625 | 06-11-2024 |
$0.24 | $0.24 | $0.24 | $0.259984 | $0.2246 | 31,330 | 06-10-2024 |
$0.25 | $0.25 | $0.25 | $0.27 | $0.25 | 3,022 | 06-06-2024 |
$0.2499 | $0.25 | $0.2499 | $0.2699 | $0.2499 | 3,274 | 06-04-2024 |
News, Short Squeeze, Breakout and More Instantly...
Alpha Tau Medical Ltd. Warrant Company Name:
DRTSW Stock Symbol:
NASDAQ Market:
Alpha Tau Medical Ltd. Warrant Website:
The pooled analysis included data from 4 i nternational clinical trials spanning a n array of hard-to-treat indications including skin, head & neck, and oral cavity. Initial response data demonstrated an overall response rate of almost 100% in tre...
JERUSALEM, May 21, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced that CFO Raphi Levy will present a corporate overview an...
- Presented preclinical data demonstrating abscopal immune effect in pancreatic murine tumor models at ESTRO 2024 Congress in Glasgow - - First patient with liver metastases treated in a feasibility and safety study of Alpha DaRT at the McGill University Health Center in Montreal, C...